Efficacy of Afoxolaner Plus Milbemycin Oxime in the Treatment of Canine

Total Page:16

File Type:pdf, Size:1020Kb

Efficacy of Afoxolaner Plus Milbemycin Oxime in the Treatment of Canine Efficacy of Afoxolaner Plus Milbemycin Oxime in the Treatment of Canine Demodicosis Camilo Romero-Núñeza Linda Guiliana Bautista-Gómeza Galia Sheinbergb Alberto Martínc Anahí Romerod Ariadna Floresa Rafael Herediaa Laura Mirandaa aCentro Universitario UAEM Amecameca, Universidad Autónoma del Estado de México, Km. 2.5 Carretera Amecameca-Ayapango, 56900, Amecameca de Juárez, Estado de México, México bCentro Veterinario México, Calle Cincinnati #22, Benito Juárez, Cd de los Deportes, 03710 Ciudad de México, México cVeterinaria Dermatología Veterinaria Especializada, Argentina No. 690, Colonia Moderna, Guadalajara, 44190 Jalisco México. dMaestría en Medicina Veterinaria, Av. Universidad 3000, Edificio A, Delegación Coyoacán, Col. Ciudad Universitaria, Cd. Universitaria, 04510 Ciudad de México, CDMX Corresponding Author: Linda Guiliana Bautista Gómez, Centro Universitario UAEM Amecameca, Universidad Autónoma del Estado de México, Carretera Amecameca-Ayapango Km 2.5, Amecameca de Juárez, 56900 Estado de México, Mexico. E-mail: [email protected] KEY WORDS: Efficacy, afoxolaner, plus milbemycin oxime in the treatment of milbemycin oxime, treatment, dog, generalized canine demodicosis. Sixty-eight demodicosis dogs diagnosed with generalized demodico- sis were included. From each dog, three skin ABSTRACT scrapings and hair samples were obtained. Demodicosis is a canine dermatosis pro- Dogs were treated with an oral dose of duced by the Demodex sp. mite; the local- 2.50–5.36 mg/kg of afoxolaner in combina- ized form can become generalized and have tion with 0.50–1.07 mg/kg of milbemycin bacterial complications, making it difficult oxime. Evaluations were made on days 7, to effectively treat. The objective was to 14, and 28 post-treatment through a lesion evaluate the efficacy of the use of afoxolaner visualization and positive samples to mites. Intern J Appl Res Vet Med • Vol. 17, No. 1, 2019. 35 After a single oral dose of afoxolaner It typically occurs in young dogs (between with milbemycin oxime, the number of 3 months and 1 year), although there are positive animals according to skin scrapings reports in dogs from two weeks of age6 and was reduced from 100% on day 1 to 17.6% in dogs older than one year, these cases tend on day 28 (P < 0.05). The resolution of the to be occasional3 or secondary to another lesions after treatment was variable, with a underlying pathology.7 significant decrease for the first 7 days. This Canine demodicosis is a common, parameter continued to decrease until the non-contagious parasitic dermatosis8 that end of the study on day 28, when a decrease can be divided into two clinical manifesta- of 94.68% was observed. An association tions: localized and generalized. Localized between the presence of Demodex sp. and demodicosis appears as small alopecic the area of the head was observed (Chi- and erythematous areas, which can regress square = 14.65, P = 0.0001). Oral adminis- spontaneously without the administration of tration of a single dose of 2.50–5.36 mg/kg treatment. Generalized demodicosis is more of afoxolaner in combination with 0.50–1.07 variable and is characterized by five or more mg/kg of milbemycin oxime is effective in affected areas or lesions that cover an entire the treatment of generalised demodicosis in region of the body, and/or pododemodicosis dogs, with a decrease in lesions in the first that involves two or more legs; the affected days of treatment. areas are erythematous, with comedones, INTRODUCTION alopecia, follicular pustules or papules and scales.9 It can be fatal in severe chronic Demodex mites are considered to be part of 10 the cutaneous microbiota of dogs. It is be- cases with secondary bacterial infection and progression of the disease is associated lieved that all dogs have a small population 2 of Demodex spp. mites in their skin,1 but with lymphadenopathy, lethargy, and fever. the manifestation of the disease is limited Diagnosis of demodicosis is usually to some animals. Under normal conditions, based on clinical signs, and is confirmed by they seem to live as commensals, feeding the presence of mites on deep skin scrap- 2 on the tallow of their hosts, thus acting as a ings, allowing for identification at different 3 pathogenic opportunists. They are transmit- stages of mite development. The manage- ted from the bitch to her puppies during the ment of canine demodicosis includes multi- 8 first days of life2 and are commonly found in modal treatment, in addition to an effective the pilosebaceous follicles.3 acaricide therapy. Demodicosis is the result of an excessive The treatment of internal parasitism is proliferation of the Demodex spp. mite. One suggested to maximize the potential of a 2 of the causes of this process is concurrent successful treatment. The currently avail- immunosuppressive conditions (specific he- able therapeutic options include: reditary immunodeficiency ofDemodex spp. • Amitraz2,4 or acquired immunosuppression). Studies • Ivermectina11 have identified the induction of demodicosis • Imidacloprid-moxidectin12,13 or by the suppression of the immune response • Doramectin14 and observed the development of the disease in strains of immunodeficient rats, in addi- Regardless of the antiparasitic drug chosen, tion to numerous clinical occurrences in im- several months of treatment, with last- munosuppressed humans and animals. These ing from three months or more, are often 15 studies have shown that immunosuppression required to achieve a clinical resolution. For all therapy options, the benefits and risks is directly associated with the development associated with the treatment must be con- of the disease, which is frequently found in dogs and rarely found in cats, resulting in sidered. For example, poor safety or toxicity from the amitraz and and environmental skin lesions consistent with demodicosis.4,5 36 Vol. 17, No.1, 2019 • Intern J Appl Res Vet Med. contamination problems are particularly as- means of a permission letter sociated with avermectins.16 ANIMALS Isoxazolines have opened a new avenue Inclusion criteria were: animals with a mini- in the therapeutic treatment of demodicosis. mum age of 8 weeks and weighing more Afoxolaner is an isoxazoline that has both than 2 kg with parasitic evidence of at least insecticidal and acaricidal activity, acting four live Demodex spp. mites (immature on GABA/glutamate receptors to inhibit or adults), confirmed by positive deep skin chloride ion channels, producing irreversible scrapings and observation of hair samples neuronal hyperexcitability and the death of under a microscope. These are in addition to arthropods.17,18 Afoxolaner has been evalu- clinical evidence of demodicosis such as: ated in dogs with generalised demodicosis using monthly oral administration. It has • Alopecia been shown to effectively reduce live mites • Erythema compared to control groups, as assessed • Comedones through skin scrapings and clinical improve- • Papules ment in dermatological lesions, without • Pustules any adverse effects,15,19 thus achieving a • Scales, or high level of efficacy for the control of this dermatosis. Currently, there is an oral • Scabs. chewable tablet formulation15 that combines Generalized demodicosis was defined the insecticidal-acaricidal compound of as a complete body region or five or more afoxolaner with the nematocidal compound localized lesions (diameter > 2.5 cm) or of milbemycin oxime (NexGard Spectra®, pododemodicosis that involved two or more 2 Boehringer Ingelheim)20,21 to provide treat- limbs. Exclusion criteria were: pregnant ment and control of endo- and ectoparasites or lactating bitches, animals undergoing in dogs.22 immunosuppressive therapy, or having been In addition, milbemycin oxime has also treated with an ectoparasitic with residual been shown to be useful for the treatment efficacy againstDemodex spp. of generalized canine demodicosis at doses Treatment Protocol of 0.5 to 2 mg/kg orally once a day.4 Due Day 1 (time of positive skin scrapings), to its ease of use, safety and efficacy, it can dogs were treated orally with 2.50–5.36 mg/ be used in all dog breeds, including Collies kg of afoxolaner and 0.50–1.07 mg/kg of and Shetland Sheepdogs.23 However, there milbemycin oxime (NexGard Spectra®). are no reports on the use of this isoxazoline The tablets were administered directly into combined with milbemycin oxime for the the oral cavity 10 minutes after eating. Skin treatment of dogs with demodicosis. There- scrapings were repeated on days 7, 14, and fore, the aim of this study was to evaluate 28. Data were recorded as the presence or the efficacy of the use of afoxolaner plus absence of live mites and a dermatological milbemycin oxime in the treatment of gen- lesion score. eralised canine demodicosis after 28 days of Diagnostic Tests treatment. Three surface scrapings (5 x 5 cm) and hair MATERIALS AND METHODS samples, and four scrapes of deep skin (1 x 1 This study protocol was approved by the cm) were taken from the most affected areas. Ethics Committee of the Amecameca Uni- During the procedure, pressure was applied versity Center of the Autonomous University to the area to be sampled to bring the mites of the State of Mexico (UAEM). Sixty-eight to the surface. Areas with primary lesions, dogs from the State of Mexico, Mexico City, such as papules and follicular pustules, were and Guadalajara, Mexico, were included, chosen. Sampling in ulcerated areas was with the prior consent of the owner, by avoided. A scalpel blade was used to collect Intern J Appl Res Vet Med • Vol. 17, No. 1, 2019. 37 Table 1. Comparison of the decrease in the presence of Demodex canis (as assessed by skin scapings) and number of lesions, after treatment with afoxolaner plus milbemycin oxime Day 1 Day 7 Day 14 Day 28 CV MEE Positive samples (%) 68 (100)a 37 (54.4)b 13 (19.1)c 12 (17.6)c 104.70 0.03 Lesions 177.37a 74.10b 33.43bc 9.47c 158.16 7.05 abc Means with different letters within a row represent a significant difference, P < 0.05 the samples.
Recommended publications
  • Evangelization and Cultural Conflict in Colonial Mexico
    Evangelization and Cultural Conflict in Colonial Mexico Evangelization and Cultural Conflict in Colonial Mexico Edited by Robert H. Jackson Evangelization and Cultural Conflict in Colonial Mexico Edited by Robert H. Jackson This book first published 2014 Cambridge Scholars Publishing 12 Back Chapman Street, Newcastle upon Tyne, NE6 2XX, UK British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library Copyright © 2014 by Robert H. Jackson and contributors All rights for this book reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the copyright owner. ISBN (10): 1-4438-5696-7, ISBN (13): 978-1-4438-5696-6 TABLE OF CONTENTS List of Maps and Figures .......................................................................... vii Maps ......................................................................................................... xii Introduction ............................................................................................ xvii Chapter One ................................................................................................ 1 The Miracle of the Virgin of the Rosary Mural at Tetela del Volcán (Morelos): Conversion, the Baptismal Controversy, a Dominican Critique of the Franciscans, and the Culture Wars in Sixteenth Century Central Mexico Robert H. Jackson Chapter Two ............................................................................................
    [Show full text]
  • Croquis De Ubicación, Plantación Y Parque Ecoturístico
    Croquis de ubicación, Plantación y Parque Ecoturístico “Bosque Esmeralda”, Emiliano Zapata, Municipio de Amecameca, Estado de México Posesionario: Ejido Emiliano Zapata (Ing. Rafael Eugenio Parrilla Arroyo) Ubicación Nezahualcóyotl Coordenadas 191919 °°° 07 17.5” geográficas: 989898 °°° 434343 ´´´ 55.8” Se localiza a 120.0 km. de la ciudad de Toluca, Ciudad de México circulando por la autopista México-Toluca, pasando La Paz por la Ciudad de México y circulando por la México- Cuautla, al llegar a Amecameca continuar a la desviación que va Ayapango, lo cual se continuará N hacía Amecameca por debajo del puente en donde la c. 5 de mayo y C. Abasolo lo cual siguiendo este camino se llega a la Plantación y al Parque W E Ecoturístico “Bosque Esmeralda” S Ixtapaluca A Puebla Chalco Cocotitlán Tlalmanalco Plantación San Antonio “Bosque Esmeralda” Tlaltecahuacan C. Abasolo San Parque Ecoturístico Francisco “Bosque Esmeralda” Zentlalpan Amecameca Croquis de ubicación, Plantación “Oztozingo”, Santiago Cuauhtenco, Municipio de Amecameca, Estado de México Propietario: Adán Contreras Hernández Ubicación Nezahualcóyotl 191919 09 15.4” Coordenadas geográficas: °°° 989898 °°° 444444 ´´´ 34.0” Se localiza a 115.0 km. de la ciudad de Toluca, circulando Ciudad de México por la autopista México-Toluca, pasando por la Ciudad de La Paz México y circulando por la México-Cuautla, con desviación a San Antonio Tlaltecahuacan, pasando este poblado N continuar a Santiago Cuauhtenco, seguir a la derecha en donde se ubica la Plantación. W E S Ixtapaluca A Puebla Plantación “Oztozingo” Chalco Santiago Cuauhtenco Cocotitlán Tlalmanalco Plantación “Oztozingo” San Antonio Tlaltecahuacan San Francisco Santiago Zentlalpan Cuauhtenco Amecameca Croquis de ubicación, Plantación “Santo Tomás”, Municipio de Atlautla, Estado de México Propietario: Alfonso González Rodríguez N Ubicación Nezahualcóyotl W E Coordenadas 181818 °°° 59 39.8” geográficas: 989898 °°° 464646 ´´´ 08.9” S La Paz Se localiza a 135.0 km.
    [Show full text]
  • Avocado Studies in Mexico in 1938
    California Avocado Association 1938 Yearbook 23: 67-85 Avocado Studies in Mexico in 1938 A. D. SHAMEL Principal Physiologist, Division of Fruit and Vegetable Crops and Diseases United States Department of Agriculture, Bureau of Plant Industry The Fuerte is the most important commercial avocado variety grown in California, since more than seventy-five per cent of the acreage and production is of that variety. This relatively high proportion is increasing because the Fuerte trees in southern California have survived low winter temperatures more successfully than most other commercial varieties. The Fuerte variety originated as a bud propagation of the parent Fuerte tree (fig. 1) that is located in the Le Blanc garden at Atlixco, state of Puebla, Mexico. The next most important commercial variety, Puebla, has been propagated in southern California from buds of a tree in the Vicente Pineda garden (fig. 2) that is located near the Le Blanc garden. The buds from the parent trees of both the Fuerte and Puebla were obtained at the same time, 1911, by Carl B. Schmidt of Mexico City, and sent to the West India Gardens at Altadena, California. The recent visit of about fifty members of the California Avocado Association and friends to Atlixco on April 17, 1938, was for the purpose of unveiling a memorial tablet at the site of the Fuerte tree and presenting medals to Alejandro Le Blanc, son of the man who planted the parent Fuerte tree, and to Carl B. Schmidt, who sent the buds to California. Appropriate congratulatory speeches were made by the Governor of the state of Puebla, the Secretary of the Mexican Department of Agriculture representatives of the U.
    [Show full text]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE
    [Show full text]
  • S/N Num Int: S/N Col: Centro Cp 56900 Entre Calles: Y Mexi
    Entidad Municipio Localidad Domicilio MEXICO AMECAMECA AMECAMECA DE JUAREZ CALLE: PARQUE NACIONAL NUM EXT: S/N NUM INT: S/N COL: CENTRO CP 56900 ENTRE CALLES: Y COACALCO DE SAN FRANCISCO CALLE: 5 DE FEBRERO NUM EXT: S/N NUM INT: S/N COL: CABECERA MUNICIPAL CP 55700 ENTRE CALLES: ESQ. MEXICO BERRIOZABAL COACALCO VICENTE GUERRERO Y S/N MEXICO COYOTEPEC COYOTEPEC CALLE: JUAN ESCUTIA NUM EXT: S/N NUM INT: COL: CHAUTONCO CP 54660 ENTRE CALLES: CONSTITUCION Y CALLE: 16 DE SEPTIEMBRE NUM EXT: 209 NUM INT: S/N COL: CENTRO CP 54800 ENTRE CALLES: 16 SE SEPTIEMBRE Y MEXICO CUAUTITLAN CUAUTITLAN AQUILES SERDAN CHALCO DE DIAZ CALLE: PORTAL DEL CIELO NUM EXT: 54 NUM INT: S/N COL: VILLAS DE CHALCO CP 56600 ENTRE CALLES: AV. DE LAS MEXICO CHALCO COVARRUBIAS TORRES Y MORELOS CALLE: MINA NUM EXT: S/N NUM INT: COL: CENTRO CP 56370 ENTRE CALLES: MEJORAMIENTO DEL AMBIENTE Y MEXICO CHICOLOAPAN CHICOLOAPAN DE JUAREZ ZARAGOZA CALLE: AVENIDA DEL PEÑON NUM EXT: S/N NUM INT: COL: BARRIO TLATELOLCO CP ENTRE CALLES: ESQUINA CALLE MEXICO CHIMALHUACAN CHIMALHUACAN HUACTLI Y MEXICO ECATEPEC DE MORELOS ECATEPEC DE MORELOS CALLE: SOL DEL NORTE NUM EXT: S/N NUM INT: COL: SAN CRISTOBAL CP 55000 ENTRE CALLES: CASA DE GOBIERNO Y CALLE: CENTER PLAZA, AV. CARLOS HANK GONZALEZ NUM EXT: 50 NUM INT: SECCION B MZ 44 COL: VALLE DE MEXICO ECATEPEC DE MORELOS ECATEPEC DE MORELOS ANAHUAC CP 55210 ENTRE CALLES: VALLE DE MEXICO Y VALLE DE JANITZIO CALLE: VIA MORELOS NUM EXT: 351 NUM INT: 1-A COL: INDUSTRIAL CERRO GORDO CP 55420 ENTRE CALLES: PLAZA MEXICO ECATEPEC DE MORELOS ECATEPEC DE MORELOS PABELLON ECATEPEC Y VIA JOSE MARIA MORELOS CALLE: LA PALMA NUM EXT: S/N NUM INT: COL: U.H.
    [Show full text]
  • Parasiticides: Fenbendazole, Ivermectin, Moxidectin Livestock
    Parasiticides: Fenbendazole, Ivermectin, Moxidectin Livestock 1 Identification of Petitioned Substance* 2 3 Chemical Names: 48 Ivermectin: Heart Guard, Sklice, Stomectol, 4 Moxidectin:(1'R,2R,4Z,4'S,5S,6S,8'R,10'E,13'R,14'E 49 Ivomec, Mectizan, Ivexterm, Scabo 6 5 ,16'E,20'R,21'R,24'S)-21',24'-Dihydroxy-4 50 Thiabendazole: Mintezol, Tresaderm, Arbotect 6 (methoxyimino)-5,11',13',22'-tetramethyl-6-[(2E)- 51 Albendazole: Albenza 7 4-methyl-2-penten-2-yl]-3,4,5,6-tetrahydro-2'H- 52 Levamisole: Ergamisol 8 spiro[pyran-2,6'-[3,7,1 9]trioxatetracyclo 53 Morantel tartrate: Rumatel 9 [15.6.1.14,8.020,24] pentacosa[10,14,16,22] tetraen]- 54 Pyrantel: Banminth, Antiminth, Cobantril 10 2'-one; (2aE, 4E,5’R,6R,6’S,8E,11R,13S,- 55 Doramectin: Dectomax 11 15S,17aR,20R,20aR,20bS)-6’-[(E)-1,2-Dimethyl-1- 56 Eprinomectin: Ivomec, Longrange 12 butenyl]-5’,6,6’,7,10,11,14,15,17a,20,20a,20b- 57 Piperazine: Wazine, Pig Wormer 13 dodecahydro-20,20b-dihydroxy-5’6,8,19-tetra- 58 14 methylspiro[11,15-methano-2H,13H,17H- CAS Numbers: 113507-06-5; 15 furo[4,3,2-pq][2,6]benzodioxacylooctadecin-13,2’- Moxidectin: 16 [2H]pyrano]-4’,17(3’H)-dione,4’-(E)-(O- Fenbendazole: 43210-67-9; 70288-86-7 17 methyloxime) Ivermectin: 59 Thiabendazole: 148-79-8 18 Fenbendazole: methyl N-(6-phenylsulfanyl-1H- 60 Albendazole: 54965-21-8 19 benzimidazol-2-yl) carbamate 61 Levamisole: 14769-72-4 20 Ivermectin: 22,23-dihydroavermectin B1a +22,23- 21 dihydroavermectin B1b 62 Morantel tartrate: 26155-31-7 63 Pyrantel: 22204-24-6 22 Thiabendazole: 4-(1H-1,3-benzodiazol-2-yl)-1,3- 23 thiazole
    [Show full text]
  • Sheet1 Page 1 a Abamectin Acetazolamide Sodium Adenosine-5-Monophosphate Aklomide Albendazole Alfaxalone Aloe Vera Alphadolone A
    Sheet1 A Abamectin Acetazolamide sodium Adenosine-5-monophosphate Aklomide Albendazole Alfaxalone Aloe vera Alphadolone Acetate Alpha-galactosidase Altrenogest Amikacin and its salts Aminopentamide Aminopyridine Amitraz Amoxicillin Amphomycin Amphotericin B Ampicillin Amprolium Anethole Apramycin Asiaticoside Atipamezole Avoparcin Azaperone B Bambermycin Bemegride Benazepril Benzathine cloxacillin Benzoyl Peroxide Benzydamine Bephenium Bephenium Hydroxynaphthoate Betamethasone Boldenone undecylenate Boswellin Bromelain Bromhexine 2-Bromo-2-nitropan-1, 3 diol Bunamidine Buquinolate Butamisole Butonate Butorphanol Page 1 Sheet1 C Calcium glucoheptonate (calcium glucoheptogluconate) Calcium levulinate Cambendazole Caprylic/Capric Acid Monoesters Carbadox Carbomycin Carfentanil Carnidazole Carnitine Carprofen Cefadroxil Ceftiofur sodium Centella asiatica Cephaloridine Cephapirin Chlorine dioxide Chlormadinone acetate Chlorophene Chlorothiazide Chlorpromazine HCl Choline Salicylate Chondroitin sulfate Clazuril Clenbuterol Clindamycin Clomipramine Clopidol Cloprostenol Clotrimazole Cloxacillin Colistin sulfate Copper calcium edetate Copper glycinate Coumaphos Cromolyn sodium Crystalline Hydroxycobalamin Cyclizine Cyclosporin A Cyprenorphine HCl Cythioate D Decoquinate Demeclocycline (Demethylchlortetracycline) Page 2 Sheet1 Deslorelin Desoxycorticosterone Pivalate Detomidine Diaveridine Dichlorvos Diclazuril Dicloxacillin Didecyl dimethyl ammonium chloride Diethanolamine Diethylcarbamazine Dihydrochlorothiazide Diidohydroxyquin Dimethylglycine
    [Show full text]
  • División Territorial Del Estado De México De 1810 a 1995
    CAMBIOS EN LOS MUNICIPIOS CAMBIOS MUNICIPIO CABECERA CATEGORIA FECHA DECRETO DESCRIPCION* MUNICIPAL* POLITICA Amecameca 30 de abril de 1875 Decreto Ne 91. Se incorporan a esta municipalidad los Amecameca de Villa pueblos de Zentlalpan y Santa Isabel Degollado Chalma, segregándose del municipio de Ayapango. 23 de abril de 1877 Decreto N9 7. Se concede a la villa de Amecameca el Amecameca de Juárez Ciudad título de ciudad, con la denominación de Amecameca de Juárez (artículos 1a y 29). 16 de octubre de 1877 Decreto Ne 55. Se erige en pueblo la ranchería de San Amecameca de Juárez Pedro Nexapa, con el nombre de San Pedro de Vicente Guerrero (artículos 12 y 2e). 16 de junio de 1899 Se suprimen varias municipalidades. Se incorpora a esta municipalidad los Amecameca de Juárez pueblos de Ayapango, Miahuacan, Pa- huacan, Tlamapa, Poxtla y San Diego; y las haciendas de Tamariz, Bautista y Retana, que integraban la extinta municipalidad de Ayapango (artículo II). 29 de agosto de 1899 Se deroga el artículo que suprime varias Se segregan de esta municipalidad los Amecameca de Juárez municipalidades. pueblos de Ayapango, Miahuacan, Pa- huacan, Tlamapa, Poxtla y San Diego; y las haciendas de Tamariz, Bautista y Retana, reincorporándose a la reerígida 1997 municipalidad de Ayapango (artículo I). 1995. 17 de septiembre de Ley Orgánica Municipal. Amecameca es municipio libre del Amecameca de Juárez a 1919 Estado de México (artículos 1e y 2e). 1810 28 de diciembre de Ley Orgánica Municipal. Amecameca es uno de los 119 Amecameca de Juárez de 1940 municipios que integran al Estado de 2 e México (artículos 1 y 2 ).
    [Show full text]
  • Derechos De Los Niños Y Las Niñas Derechos De La
    PROFAMIN 27 Asistentes: 2,135 personas. DERECHOS detectándose que en la escuela DERECHOS DE existen elementos suficientes que no DE LOS NIÑOS permiten el óptimo y sano desarrollo Y LAS NIÑAS LA MUJER de los menores. Fechas: 01, 02, 03, 04, 06, 08, Fechas: 01, 02, 03, 04, 08, 09, En fecha seis de julio, este 09, 15, 18, 25, 28, 29 y 30 de 25, 28 y 29 de julio, así como 02, Organismo protector de derechos julio, así como 02, 05, 06, 07, 08, 06, 07, 19, 21, 26 y 28 de agosto. humanos, en coordinación con el 10, 21, 26, 27 y 28 de agosto. Instituto de Seguridad Social del Municipios: Almoloya de Juárez, Estado de México y Municipios; el Municipios: Acolman, Almoloya de Calimaya, Ixtlahuaca, Malinalco, Instituto de Salud del Estado de Alquisiras, Almoloya de Juárez, Tenancingo, Tenango del Valle, México y el Consejo Estatal de Amecameca, Atizapán de Toluca y Tultepec. Población, como parte de la Zaragoza, Atlacomulco, Calimaya, Comisión Técnica que coordinó en Valle de Chalco Solidaridad, Asistentes: 1,516 personas. el territorio estatal las casillas Chalco, Coacalco de Berriozábal, itinerantes del IFE, dieron inicio a Cuautitlán Izcalli, Ecatepec de ACTIVIDADES la tercera etapa del programa, Morelos, El Oro, Huixquilucan, participando niños, niñas y Ixtapan de la Sal, Ixtlahuaca, RELEVANTES adolescentes de 6 a 14 años de Jilotepec, Lerma, Metepec, edad que se encontraban Naucalpan de Juárez, El día tres de julio se realizó una hospitalizados; niños trabajadores Nezahualcóyotl, Ocoyoacac, impresión diagnóstica relacionada de centros comerciales (cerillos), Otzolotepec, San Felipe del con el expediente de queja niños de y en la calle de Progreso, Tianguistenco, Tecámac, CODHEM/TOL/164/2003-1, que los municipios de: Acolman, Tejupilco, Tenancingo, Tenango del se tramita en la Primera Visitaduría Almoloya de Alquisiras, Amecameca, Valle, Teotihuacán, Texcoco, Toluca, General, área que solicitó el apoyo Atizapán de Zaragoza, Tultepec, Tultitlán, Valle de Bravo y de los Departamentos de Psicología Atlacomulco, Coacalco de Zumpango.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2013/0143956A1 Cady Et Al
    US 2013.0143956A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0143956A1 Cady et al. (43) Pub. Date: Jun. 6, 2013 (54) LONG-ACTING INJECTABLE MOXIDECTIN (22) Filed: Nov.30, 2012 FORMULATIONS AND NOVEL MOXDECTIN CRYSTAL FORMS Related U.S. Application Data (71) Applicants: Susan Mancini Cady, Yardley, PA (US); (60) Provisional application No. 61/566,336, filed on Dec. Baoqing Ma, Kendall Park, NJ (US); 2, 2011. Robert Clark Chapman, Downingtown, Publication Classification PA (US); Chunhua Yang, Edison, NJ (US); Uday Jain, Plainsboro, NJ (US) (51) Int. Cl. A6IK3I/365 (2006.01) (72) Inventors: Susan Mancini Cady, Yardley, PA (US); (52) U.S. Cl. Baoqing Ma, Kendall Park, NJ (US); CPC .................................... A61 K3I/365 (2013.01) Robert Clark Chapman, Downingtown, USPC ............................ 514/450; 549/264; 264/145 PA (US); Chunhua Yang, Edison, NJ (US); Uday Jain, Plainsboro, NJ (US) (57) ABSTRACT This invention provides for novel antiparasitic and pesticidal forms of moxidectin, including a long-acting polymeric (73) Assignee: Merial Limited, Duluth, GA (US) implant. The resulting compounds may be used in veterinary compositions which are used in treating, controlling and pre (21) Appl. No.: 13/690,185 Venting of endo- and ectoparasite infections in animals. Patent Application Publication Jun. 6, 2013 Sheet 1 of 33 US 2013/0143956 A1 FIG. I. Six: Restivati Masaaaaaaaaaaaaaaaaaaaaaaaaaaa estivate 83 3 R33 Patent Application Publication Jun. 6, 2013 Sheet 2 of 33 US 2013/0143956 A1 FIG 2A Conventional DSC of Moxidectin lot SO9060: ... -- ; : f; : : ^ ‘s 1119°C f ---. f - “r-. f a. -: ; Agree 18649°Cs f 2) skirt" ----.
    [Show full text]
  • Directorio De Juzgados Del Poder Judicial Del Estado De México
    “2012. AÑO DEL BICENTENARIO DE EL ILUSTRADOR NACIONAL” DIRECTORIO DE JUZGADOS DEL PODER JUDICIAL DEL ESTADO DE MÉXICO RDRM “2012. AÑO DEL BICENTENARIO DE EL ILUSTRADOR NACIONAL” I. DISTRITO JUDICIAL DE CHALCO 2 “2012. AÑO DEL BICENTENARIO DE EL ILUSTRADOR NACIONAL” I.- DISTRITO JUDICIAL DE CHALCO JUZGADOS PENALES DE PRIMERA INSTANCIA JUZGADO TITULAR DIRECCIÓN JURISDICCIÓN TELÉFONO Chalco, Amecameca, Atlautla, Ayapango, Cocotitlán, Ecatzingo, Carretera Chalco San Andrés Penal de Primera Ixtapaluca, Juchitepec, Ozumba, Lic. Ramsés Tovar García Mixquic, San Mateo, Huitzilzingo 01 55 59 88 62 01 Instancia de Chalco Temamatla, Tenango Del Aire, Chalco, México. C. P. 56625 Tepetlixpa, Tlalmanalco Y Valle De Chalco Solidaridad JUZGADO MIXTO JUZGADO TITULAR DIRECCIÓN JURISDICCIÓN TELÉFONO Carretera Chalco San Andrés Mixto de Cuantía Lic. Jaime Velázquez Mixquic, San Mateo Huitzilzingo Chalco, Cocotitlán 01 55 59 88 71 37 Menor de Chalco Melgarejo Chalco, México. C. P. 56625 3 “2012. AÑO DEL BICENTENARIO DE EL ILUSTRADOR NACIONAL” JUZGADOS CIVILES DE PRIMERA INSTANCIA JUZGADO TITULAR DIRECCIÓN JURISDICCIÓN TELÉFONO Carretera Chalco San Andrés 01 55 59 88 75 59 1° Civil de Primera M. en D. Luz Irene Mixquic San Mateo Huitzilzingo Chalco, Cocotitlán Instancia de Chalco Hernández Rosas Chalco, México. C. P. 56625 2° Civil de Primera Calle 7 s/n, 7, Fraccionamiento Instancia del Distrito Lic. Sandra Norma Cruz Los Héroes, Sección II (El Judicial de Chalco Ixtapaluca 01 55 59 72 41 09 Giles Texontle) Ixtapaluca, México. con Residencia en C. P. 56530 Ixtapaluca 3° Civil de Primera Fracción del Lote I, de la Amecameca, Atlautla, Ecatzingo, Instancia del Distrito Hacienda de San Miguel M.
    [Show full text]
  • Alpaca and Llama Parasite Treatment
    Alpaca and Llama Parasite Treatment Albendazole (Valbazen) 10mg/kg Do not recommend in pregnancy or for young crias! Much better for killing tapeworms than Fenbendazole. Give orally - 6cc/100 pounds of body weight. Give one dose once per day for three days in a row (max). May need to repeat in two weeks depending on parasite load. May also have an ovacidal effect – meaning that it kills eggs and thus prevents pasture contamination – therefore it is good for isolation pens. Doramectin (Dectomax) 1cc/50 pounds of body weight every 8 weeks. Or give 1cc/70 pounds of body weight every 6 weeks. Give SubQ. (Recommend 20 gauge needle) Primarily for Meningeal Worm prevention. May kill some strongyles. Probably ineffective against most Nematodirus and Trichuris. Ivermectin (Ivomec) 1cc/70 pounds of body weight for Meningeal Worm prevention. Note that efficacy lasts for no more than 4 weeks max! Excellent for mange treatment: Dose at 1cc/50 pounds for mange – 3 days in row, and then repeat one dose in one week. Do not give mange treatment to pregnant females within first 60 days of pregnancy! Give SubQ. (Recommend 20 gauge needle) Probably ineffective in llamas and alpacas for Trichuris, Nematodirus, Moniezia, some strongyles, and liver flukes. You can purchase Ivomec Plus to kill liver flukes. Fenbendazole (Panacur or Safeguard) 20mg/kg or 1cc/10 pounds of body weight Give orally three days in row for Nematodirus. Give orally 5 days in a row and repeat in 2 weeks for Trichuris and Moneizia (tapeworms). This is a very safe drug, even for very young crias and newly pregnant females! Levamisole 8mg/kg Oral drug is safer than the injectible version.
    [Show full text]